US patent US12774323
Anti-apolipoprotein e (APOE) antibodies and polynucleotides thereof
Abstract
Methods and compositions for preventing or treating cognitive decline associated with dementia and/or mild cognitive impairment and/or neurodegeneration using antibodies, peptides, fusion proteins, or genome editing systems that modulate HSPG/heparin binding affinities of ApoE.